Announced
Completed
Synopsis
Kester Capital-backed MAP Patient Access, a company in market access consulting services to the pharmaceutical and biotech sectors, completed the acquisition of AxTalis, a consultancy firm supporting Biopharma and Medtech companies in Regulatory Affairs, Market Access and Medical Affairs. Financial terms were not disclosed. "We are excited to become part of the Group. This acquisition opens up new opportunities for us to deliver even greater value to our clients. Together, we will continue to drive positive change and broaden access to therapeutic solutions through collaboration with physicians, researchers, companies, health authorities and patients," Sven Tops and Frank Vanderdonck, AxTalis Co-Founders and Managing Partners.
Principals
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.